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Abstract Mitochondria play key roles in a broad range of
biomedical situations, consequently there is a need to direct
bioactive compounds to mitochondria as both therapies and
probes. A successful approach has been to target com-
pounds to mitochondria by conjugation to lipophilic cations,
such as triphenylphosphonium (TPP), which utilize the large
mitochondrial membrane potential (Δ=m, negative inside)
to drive accumulation. This has proven effective both in
vitro and in vivo for a range of bioactive compounds and
probes. However so far only neutral appendages have been
targeted to mitochondria in this way. Many bioactive func-
tional moieties that we would like to send to mitochondria
contain ionisable groups with pKa in the range that creates
an assortment of charged species under physiological con-
ditions. To see if such ionisable compounds can also be
taken up by mitochondria, we determined the general
requirements for the accumulation within mitochondria of
a TPP cation conjugated to a carboxylic acid or an amine.
Both were taken up by energised mitochondria in response
to the protonmotive force. A lipophilic TPP cation attached
to a carboxylic acid was accumulated to a greater extent than
a simple TPP cation due to the interaction of the weakly
acidic group with the pH gradient (ΔpH). In contrast, a
lipophilic TPP cation attached to an amine was accumulated
less than the simple cation due to exclusion of the weakly
basic group by the ΔpH. From these data we derived a
simple equation that describes the uptake of lipophilic cations
containing ionisable groups as a function of Δ=m, ΔpH and
pKa. These findings may facilitate the rational design of
additional mitochondrial targeted probes and therapies.
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Mitochondrial function and dysfunction are at the centre of a
range of vital biomedical processes and contribute to
numerous pathologies (Duchen and Szabadkai 2010; Smith
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et al. 2011; Wallace et al. 2010). Consequently there is a
need to develop mitochondria-targeted probes and therapies
(Murphy 2009; Murphy and Smith 2007; Smith et al. 2011).
One way in which the targeting of bioactive molecules to
mitochondria has been achieved is by conjugation to
lipophilic cations such as triphenylphosphonium (TPP)
(Murphy and Smith 2007; Ross et al. 2005; Smith et al.
2011). The hydrophobic surface and the large ionic radius
mean that the TPP cation can move directly and rapidly
through biological phospholipid bilayers, without requiring
a protein transporter (Ross et al. 2005). The positive charge
facilitates TPP cations to be taken up into mitochondria
driven by the large mitochondrial membrane potential
(Δ=m) of~170 mV (negative inside) (Ross et al. 2005).
The extent of this uptake, generally described by the
Nernst equation, leads to their several hundred fold uptake
into mitochondria in vivo (Fig. 1a) (Ross et al. 2005). This
has led to the development of a wide range of bioactive
molecules and probes that can be delivered to mitochondria
in vivo, following oral, intravenous, intraperitoneal or sub-
cutaneous administration (Porteous et al. 2010; Smith et al.
2011). These compounds include antioxidants such as
MitoQ (Kelso et al. 2001; Smith and Murphy 2010) and
MitoCP (Dhanasekaran et al. 2005), the S-nitrosating com-
pound MitoSNO (Prime et al. 2009), the superoxide probe
MitoSOX (Robinson et al. 2006) and the hydrogen peroxide
probes MitoB (Cocheme et al. 2011) and MitoPY1
(Dickinson and Chang 2008). One of these compounds,
MitoQ, has been progressed through phase II trials in
humans, indicating the potential of this strategy to develop
pharmaceuticals (Gane et al. 2010; Snow et al. 2010).
However, all the TPP compounds that have been targeted
to mitochondria to date by this strategy have contained a
neutral bioactive component. Many bioactive compounds
that we would like to target to mitochondria to act as drugs
or probes have ionisable groups, typically carboxylic acid or
Fig. 1 Mitochondrial uptake of
lipophilic cations, acids and
bases. a Uptake of a lipophilic
TPP cation conjugated to an
uncharged moiety (X). The
uptake of this compound into
mitochondria is driven by the
Δ=m and the extent of uptake is
given by the Nernst equation. b
The distribution of lipophilic
weak acids and bases across the
mitochondrial inner membrane
in response to ΔpH. Only the
neutral forms are membrane
permeant. Equilibration with
the local pH means that the
lipophilic weak acids are
accumulated into the basic
mitochondrial matrix while
lipophilic amines are excluded.
The extents of this uptake or
exclusion are given by the
indicated equations derived
from the Henderson-Hasselbalch
equation. For both acid and base
the charged form is >>99 % of
the total present, consequently
these equations describe the total
distribution of weak acids and
bases across the mitochondrial
inner membrane
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amine functions. Under physiological conditions, conjuga-
tion of these moieties to the TPP cation, will generate com-
pounds with a range of protonation and charge states. For
example, a carboxylic acid (pKa~5) attached to a TPP cation
will be largely present as a neutral zwitterion, while a TPP
attached to an amine (pKa~10) would be predominantly a
dication. A neutral zwitterion would not be expected to be
taken up into mitochondria driven byΔ=m, while a dication
may be too highly charged to cross the mitochondrial inner
membrane (Ross et al. 2006). Furthermore, lipophilic weak
acids and bases themselves distribute across the mitochon-
drial inner membrane in response to the pH gradient across
the mitochondrial inner membrane (ΔpH, basic inside)
(Fig. 1b) (Azzone et al. 1984; Brand 1995). Only the un-
charged form crosses the membrane and then equilibrates with
the local pH, consequently weak lipophilic acids are accumu-
lated by mitochondria due to the higher pH of the matrix,
while weak lipophilic bases are excluded (Fig. 1b). It is
unclear how the conjugation of an ionisable group to a TPP
cation affects its uptake in response to ΔpH. Together these
issues are a significant impediment to the rational develop-
ment of further mitochondria-targeted probes and therapies
incorporating carboxylic acid or amine functions. To address
this gap in our knowledge, here we report on the uptake by
mitochondria of a TPP cation conjugated to a carboxylic acid
(10-carboxydecyl)triphenylphosphonium (TPP+C10CO2H),
or to an amine (10-aminodecyl)triphenylphosphonium
(TPP+C10NH2) (Fig. 2). In both cases the ionisable function
was attached to the TPP by a hydrophobic alkyl chain in order
to mimic many widely used mitochondria-targeted com-
pounds. From this, we develop a general model for how these
molecules are accumulated into mitochondria and derive an
equation that describes the dependence of this uptake on
Δ=m, ΔpH and pKa. These findings provide a rational basis





(TPP+C10CO2H) was prepared as described (Wube et al.
2011). (10-Aminodecyl)triphenylphosphonium bromide as
the hydrobromide salt (Lopez et al. 2009) was prepared by
heating 10-bromo-1-decanamine, hydrobromide (0.915 g,
2.89 mmol) (Klayman et al. 1969) with triphenylphosphine
(7 g, 26.7 mmol) in a sealed tube at 100 °C for 24 h under
argon. The mixture was then cooled, dissolved in a mini-
mum of ethanol and precipitated by adding to diethyl ether
(100 mL) to give the product as a white solid (1.20 g,
2.07 mmol, 72 %). HPLC: Column Phenomenex Prodigy
250 ×3mm, gradient elution 10 % acetonitrile/H2O (0.1 %
trifluoroacetic acid) to 100 % acetonitrile over 12.5 min at
0.5 mLmin-1. Detection at 210 and 254 nm. Retention time
Fig. 2 Structures and pKa
values of the TPP compounds
assessed. The pKa values are
estimated from literature
values of similar compounds:
TPP+C10CO2H (Kanicky and
Shah 2003); TPP+C10NH2
(Hoerr et al. 1943)
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9.07 min 100 % pure. 1H NMR (400 MHz, CDCl3) δ 8.1
(3H, broad, NH), 7.8–7.4 (15H, m, ArH,), 3.75 (2H, m,
CH2P), 3.05 (2H, m, CH2N), 1.9 (2H, m, CH2), 1.7–1.2
(14H, m, CH2) ppm.
31P NMR: δ 24.4 ppm. Stock solutions
of the TPP compounds used (Fig. 2) were made up in absolute
ethanol, flushed with argon and stored at −20 °C prior to use.
Mitochondrial preparation
Liver mitochondria (RLM) were prepared from 6 to
13 weeks old female Wistar rats (300–500 g) by homogeni-
sation followed by differential centrifugation in ice-cold
250 mM sucrose, 5 mM Tris–HCl, 1 mM EGTA, pH 7.4
(Chappell and Hansford 1972). The mitochondrial suspen-
sion was stored on ice until use. Mitochondrial protein
concentration was determined by the biuret assay using
bovine serum albumin as a standard (Gornall et al. 1949).
Incubations were carried out in KCl buffer (120 mM KCl,
1 mM EGTA, 10 mM HEPES, adjusted to pH6, 7.2 or 8).
Ion-selective electrode measurements
Ion-selective electrodes sensitive to the TPP cation moiety
of methyltriphenylphosphonium (TPMP), TPP+C10CO2H
and TPP+C10NH2 were constructed as previously described
(Asin-Cayuela et al. 2004) and placed into a thermostated
(37 °C) and stirred 3 mL incubation chamber containing
rotenone (4 μgmL-1) supplemented KCl buffer.
HPLC measurements
RLM (0.5 mg protein/mL) were incubated in 4 mL KCl
buffer supplemented with rotenone (4 μg/mL) in open
15 mL plastic tubes in a shaking water bath at 25 °C.
Respiration was initiated by addition of succinate (4 mM)
and in some cases carbonylcyanide p-trifluoromethoxyphe-
nylhydrazone (FCCP) (1 μM) was added 4 min later. For the
malonate incubations, the TPP compounds were added after
RLM had been energized with succinate (4 mM, supple-
mented with 0.6 mM or 2.3 mM malonate). After a further
5 min the mitochondria were pelleted by centrifugation
(7,500×g for 10 min). Supernatants were removed and
stored at 4 °C in eppendorf tubes until reverse phase (RP)-
HPLC analysis. The mitochondrial pellets were extracted by
vortexing in 250 μL Buffer B (100 % acetonitrile (ACN),
0.1 % trifluoroacetic acid (TFA)) followed by centrifugation
(7,500×g for 10 min). Supernatant (250 μL) was removed
and stored at 4 °C in glass vials (Chromacol®). All samples
were diluted to 25 % ACN by addition of Buffer A (100 %
H2O, 0.1 % TFA), filtered through a Milipore® Millex®
syringe-driven filter unit (0.22 μm) and then injected into
a 2 mL sample loop and separated by RP-HPLC. For this a
C18 column (Jupiter 300A, Phenomenex®) with a Widepore
C18 Guard Column (Phenomenex®) and a Gilson 321
pump were used. A gradient of buffer A and B was run at
1 mL/min (% B): 0–5 min, 5 – 15 %; 5 – 31 min, 15 –
100 %; 31–35 min, 100 – 5 %. Peaks were detected at
220 nm using a Gilson UV/VIS 151 spectrophotometer.
TPMP, TPP+C10CO2H and TPP
+C10NH2 standards were
used to determine elution times, and the Chart 5 software
(ADInstruments®) was used to calculate peak areas.
Accumulation ratios of the TPP cations between the mito-
chondrial matrix and the extra-mitochondrial environment
were calculated by normalizing the ratios of the TPP cation
peak areas to their corresponding volumes: 0.6 μL/mg pro-
tein for the mitochondrial matrix (Brand 1995) and 4 mL for
the extra-mitochondrial environment.
Partition coefficients
The 1-octanol/phosphate buffered saline (PBS) partition
coefficients of the TPP compounds were measured as de-
scribed previously (Kelso et al. 2001). In brief, TPP cation
(400 nmol) was added to 2 mL PBS-saturated 1-octanol and
mixed for 60 min at 37 °C with 2 mL 1-octanol saturated PBS
in a sealed 10 mL Kimax® glass tube. After phase separation
by centrifugation (5 min, 870×g at RT) the concentrations in
the two phases were measured at 268 nm relative to standard
curves in 1-octanol saturated PBS or PBS saturated 1-octanol.
For pH dependent partition coefficients, PBS was adjusted
with HCl or KOH prior to 1-octanol saturation.
Results
Mitochondrial uptake of a TPP conjugated carboxylic acid
or amine
We first assessed if the TPP conjugated carboxylic acid
(TPP+C10CO2H) and amine (TPP
+C10NH2) were taken up
by isolated mitochondria in response to the generation of a
protonmotive force (Δp), using a TPP-selective electrode
(Fig. 3). When mitochondria incubated at the intracellular
pH of 7.2 were energized with succinate this led to the
significant uptake of the simple TPP cation TPMP, and also
of TPP+C10CO2H and TPP
+C10NH2. All three were released
from mitochondria upon abolishing the Δp by uncoupling
with FCCP. The accumulation ratios (ACRs) were~1,000–
1,500 and~3,000–4,000, for the TPP+C10NH2 and
TPP+C10CO2H cations, respectively (Fig. 3). To see if the
ΔpH component of Δp contributed to uptake, we abolished
the ΔpH by addition of the K+/H+ exchanger nigericin
(Fig. 3). This led to an increase of Δ=m as the magnitude
of the Δp is retained but is now only in the form of
Δ=m, as is demonstrated by the increased accumulation
of TPMP. Nigericin significantly increased the accumulation
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of TPP+C10NH2, but only slightly increased that of
TPP+C10CO2H. This suggests thatΔpH enhanced the uptake
of TPP+C10CO2H, but decreased that of TPP
+C10NH2,
relative to the uptake driven by Δ=m alone.
To assess further the influence of pH on the mitochon-
drial uptake of these TPP compounds, we incubated mito-
chondria in media at pH6 or 8 (Fig. 3). The uptake of TPMP
was similar at all pH values, indicating that mitochondria
were functional under these conditions. The rate of uptake
of TPP+C10CO2H was increased at pH 6 but decreased at
pH8. As the pKa for a C10 carboxylic acid is ~4.9 (Kanicky
and Shah 2003), the proportion of TPP+C10CO2H in the
singly (positively) charged state will decrease as the pH
increases and will be~10 %, ~ 1 % and~0.1 % at pH6, 7
and 8, respectively. For TPP+C10NH2 at pH 6 there was
hardly any uptake while the profile of uptake at pH7.2 was
similar to that at pH8. The pKa of decylamine is ~10.6
(Hoerr et al . 1943), so the free amine fractions
(TPP+C10NH2) at pH6, 7.2 and 8 are ~0.001 %, ~ 0.01 %
and ~0.1 %, respectively. To assess the effect of pH on the
hydrophobicity of TPP+C10CO2H and TPP
+C10NH2, we
measured their 1-octanol:PBS partition coefficients over
the same pH range (Table 1). This showed that pH had little
Fig. 3 Mitochondrial accumulation of TPP+C10CO2H, TPP
+C10NH2
and TPMP assessed by ion-selective electrode (ISE) measurements
at different pH values. The ISE electrode response was calibrated
by 5×1 μM additions of the investigated compound. Then RLM
(0.5 mg protein/mL) were added followed by succinate (10 mM).
Nigericin (100 nM) or FCCP (1 μM) were added where indicated.
Data are typical traces that were repeated 3–4 times with the
same result
Table 1 pH dependent 1-Octanol/PBS partition-coefficients
Compound pH6 pH7.2 pH8
TPMP 2.3±0.2 2.2±0.5 2.0±0.1
TPP+C10COOH 17.3±1.6 14.8±1.7 13.2±0.9
TPP+C10NH2 2.1±0.7 3.5±0.2 3.1±0.2
Data are means ± SEM (n03 to 5)
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effect on the partition coefficient of TPMP and that
TPP+C10CO2H is significantly more hydrophobic than
TPP+C10NH2 at all pH values. The hydrophobicity of
TPP+C10CO2H increases when pH decreased, consistent
with greater partition into 1-octanol of the protonated mono-
cationic form over the zwitterion. This was strongly sup-
ported by measurements of its partition coefficient at pH02,
where it was 108±24 indicating that the monocation form is
considerably more soluble in a hydrophobic phase than the
zwitterion and is likely the predominant form that passes
through the membrane. For TPP+C10NH2 the negligible
change of the partition coefficient with pH is presumably
because at all pH values the majority (>99.9 %) is in the
dicationic form. Together these findings suggest that the TPP
conjugated carboxylic acid is taken up through the mitochon-
drial inner membrane in its monocationic, protonated form,
TPP+C10CO2H and that TPP
+C10NH2 is taken up as the
monocationic, free amine form with negligible uptake of the
dication, consistent with the constrained mitochondrial uptake
of dications compared to monocations (Ross et al. 2006).
To extend the semi-quantitative ion-selective electrode
experiments and to quantify the effects of Δ=m, ΔpH and
pH on the accumulation of the TPP-cations, we next
assessed their uptake into energized mitochondria by RP-
HPLC (Fig. 4). Mitochondria were incubated with both
TPP+C10CO2H and TPP
+C10NH2 simultaneously, to avoid
inter-incubation variations, and their accumulation ratios
(ACRs) determined by measuring the amounts in the mito-
chondrial pellets and supernatants (Fig. 4a). This analysis
showed that the ACR for TPP+C10CO2H was unaffected by
nigericin, while that of TPP+C10NH2 increased, consistent
with the presence of a ΔpH enhancing the uptake of
TPP+C10CO2H but decreasing that of TPP
+C10NH2. When
the ACRs for the two cations were measured simultaneously
over a range of pH values the uptake of TPP+C10CO2H
decreased as the pH was raised, while that of TPP+C10NH2
increased (Fig. 4b), consistent with the electrode measure-
ments (Fig. 3). The minimal effect of nigericin on
TPP+C10CO2H uptake may be due to two opposing effects:
by decreasing ΔpH nigericin lowers the uptake of
TPP+C10CO2H that is due to weak acid accumulation, while
in parallel increasing the Δ=m will enhance uptake due to
the TPP+ component. To assess this possibility, we mea-
sured the ACR for the uptake of TPP+C10CO2H and TPMP
in the same mitochondrial incubations ± nigericin (Fig. 4c).
We then normalised the uptake of TPP+C10CO2H to that of
TPMP to distinguish between the effects of nigericin due to
changes in the ΔpH from those due to altering Δ=m
(Fig. 4c). This analysis showed that the TPMP-normalised
uptake of TPP+C10CO2H was decreased significantly by
abolishing theΔpH and confirms that the extensive mitochon-
drial uptake of TPP+C10CO2H is due in part to the presence of
a ΔpH across the mitochondrial inner membrane.
Model for the mitochondrial uptake of TPP conjugated
carboxylic acids and amines
Together these findings are consistent with a simple model for
the uptake of TPP+-conjugated carboxylic acids and amines by
mitochondria (Fig. 5). In this only the monocationic
(TPP+C10CO2H or TPP
+C10NH2) forms of the molecules cross
Fig. 4 Mitochondrial accumulation of TPP+C10CO2H, TPP
+C10NH2
and TPMP assessed by RP-HPLC. a The accumulation ratios (ACRs)
of TPP+C10CO2H and TPP
+C10NH2 were measured simultaneously in
mitochondrial incubations ± nigericin at pH 7.2. b ACR of
TPP+C10CO2H and TPP
+C10NH2 measured simultaneously in
mitochondrial incubations at different pH values. c The ACRs of
TPP+C10CO2H and TPMP were measured simultaneously in
mitochondrial incubations ± nigercin and the ACR of TPP+C10CO2H
was normalised to that of TPMP. Data are means ± SEM of three
independent incubations. Statistical significance was determined by
two-tailed Student’s t-tests (*P<0.01, **P<0.001, ***P<0.0001)
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the mitochondrial inner membrane and thereby equilibrate with
the Δ=m, as described by the Nernst equation. The monoca-
tionic forms then equilibrate with the local pH in the cytosol and
matrix to form a dication (TPP+C10NH3
+) or a zwitterion
(TPP+C10CO2
-), neither of which is membrane permeant.
Consequently, for TPP+C10CO2H a conventional mitochondrial
ΔpH will lead to a greater uptake of the compound into the
matrix compared to a simple TPP cation at that Δ=m. In
contrast, for TPP+C10NH2 the presence of aΔpH will decrease
the uptake relative to that of a simple TPP cation at thatΔ=m.
Measurement of the overall ACR of these compounds
does not distinguish between protonation states, therefore
the mitochondrial uptake of lipophilic cations conjugated to
amines or carboxylic acids will depend on both the Δ=m
and the ΔpH. Furthermore, as the interaction of the mole-
cules with ΔpH depends on their protonation states, the pKa
of the carboxylic acid or amine will also contribute. Using
this model we generated a simple equation to describe the
experimental ACR for lipophilic cations conjugated to acids
or bases as a function of Δ=m, ΔpH and pKa (Eq. 1: see
Supplementary Material for the derivation).
ACR ¼ 1þ 10
i pHmpKað Þ





For a lipophilic cation-conjugated to an acid i is +1 and for a
base i is −1. F 0 Faraday constant, R 0 universal gas
constant, T 0 absolute temperature. Note that lipophilic
cations adsorb extensively to the matrix-facing surface of
the mitochondrial inner membrane, consequently the exper-
imentally observed ACR will be greater than predicted by
Eq. 1 and will be related to the predicted ACR by a binding
correction (Brown and Brand 1985).
Two general cases illustrate the implications of this equa-
tion: a TPP+ conjugated to an acidic function, where a
membrane-impermeant zwitterion is generated at high pH,
and a TPP+ conjugated to a basic function, where a
membrane-impermeant dication is generated at low pH. At
plausible values for Δ=m (170 mV) and ΔpH (0.8; pH
matrix08, pH cytosol07.2) Eq. 1 generates the ACR for a
TPP cation conjugated to an acidic function (Fig. 6a) or to a
basic function (Fig. 6b) as a function of the pKa. These ACR
values are given as a percentage of that for a simple TPP
cation lacking an exchangeable group. For a TPP cation
conjugated to an acidic function the uptake into mitochondria
increases compared to that of a simple TPP cation as the pKa
drops below ~8. This is due to the extra accumulation driven
by theΔpH, in addition to that byΔ=m (Fig. 6a). In contrast,
for a lipophilic cation conjugated to a basic function the
uptake into mitochondria decreases relative to that of a simple
TPP cation as the pKa increases (Fig. 6b). This is due to the
exclusion of weak bases from the mitochondrial matrix by the
ΔpH acting counter to the accumulation driven by Δ=m.
These predictions of Eq. 1 are consistent with the experimen-
tal measurements of the uptake of TPP+C10CO2H and
TPP+C10NH2 into mitochondria seen in Figs. 4 and 5.
From Eq. 1 the ACR for TPMP should be a linear
function of that of TPP+C10CO2H or TPP
+C10NH2 with a
slope given by the coefficient in Eq. 1, adjusted by a
correction constant dependent on the extent of binding to
the matrix face of the mitochondrial inner membrane of
TPMP relative to TPP+C10CO2H or TPP
+C10NH2. To see
if this was the case, we measured the ACRs of TPP+C10CO2H
or TPP+C10NH2 relative to those of TPMP over a range
of Δ=m values set by different amounts of the respiratory
inhibitor malonate (Fig. 7). The measured ACRs of
Fig. 5 Model for the uptake by energised mitochondria of a lipophilic
cation conjugated to a carboxylic acid or amine function. A TPP
conjugated to an acidic function generates a membrane-impermeant
zwitterion and a membrane permeant singly charged species which is
accumulated in response to Δ=m. Within the mitochondrial matrix the
ΔpH leads to greater net accumulation of the lipophilic cation. For a
TPP conjugated to a basic function, a membrane-impermeant dication
is generated along with a membrane permeant species that is
accumulated in response to Δ=m. Within the mitochondrial matrix
the ΔpH leads to the decreased formation of the membrane-
impermeant dication and hence to a decreased overall accumulation
of the lipophilic cation
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TPP+C10CO2H (Fig. 7a) or TPP
+C10NH2 (Fig. 7b) were
both linear functions of the measured TPMPACR, consistent
with Eq. 1. Furthermore, the slopes of the lines are consistent
with the relative partition coefficients shown in Table 1.
Discussion
This study enables us to draw some important conclusions
about the use of lipophilic cations to deliver therapeutic and
probe compounds to mitochondria. The most important of
these is that lipophilic cations containing weakly acidic or
basic groups such as carboxylic acids or amines can be effec-
tively targeted to mitochondria. This opens up many possibil-
ities for the delivery of a wide range of further compounds to
mitochondria as potential therapeutics, bioactives or probes.
Interestingly, the incorporation of a weak acid significantly
enhanced the extent of uptake of a lipophilic cation by ener-
gised mitochondria. This suggests that it may be possible to
incorporate a weak acid function into lipophilic cations to
further increase the extent of mitochondrial uptake. The
combined response to a Δ=m and to a ΔpH, and the fact that
this can be quantified by Eq. 1, suggests that it may be
possible to use a TPP cation conjugated to a weak acid to
assess the mitochondrialΔpH in vivo. This could be achieved
by comparing the uptake of a compound such as
TPP+C10CO2H with that of a closely related TPP cation lack-
ing an exchangeable group. Their distribution in cell systems
or in vivo could be measured by LC/MS/MS relative to
deuterated internal standards, as we have done previously with
MitoB (Cocheme et al. 2011) to quantify mitochondrial H2O2
production in vivo. Hence this work leads to new possibilities
for assessing the mitochondrial ΔpH in vivo, something that
is currently not possible. For lipophilic cations conjugated to
weak bases the situation is somewhat different, with the
presence of a weak base decreasing net uptake. Thus while
mitochondria-targeted lipophilic cations containing weakly
basic moieties can be directed to mitochondria, when possible
they should be excluded to enhance uptake.
We have generated a simple model and equation for the
uptake of lipophilic cations conjugated to weak acids and
bases, the derivation of which is shown in the Supplementary
Material. These gave a reasonable description of the behaviour
Fig. 6 Predicted uptake of a lipophilic cation conjugated to an acidic
group or basic group as a function of pKa. Equation 1 was used to calculate
the ACR for a TPP+ conjugated to an acidic function a, where amembrane-
impermeant zwitterion is generated at high pH, and a TPP+ conjugated to a
basic function b, where a membrane-impermeant dication is generated at
low pH. The mitochondrial Δ=m was set at 170 mV, the ΔpH was set at
0.8, the mitochondrial matrix pH was set at 8 and that of the cytosol at 7.2.
The calculated ACR is expressed as a percentage of that of a simple TPP
cation that does not contain an ionisable group (dashed line)
Fig. 7 Uptake of TPP+C10CO2H and TPP
+C10NH2 relative to TPMP
over a range of Δ=m values. Mitochondria were incubated with
TPP+C10CO2H and TPMP a or with TPP
+C10NH2 and TPMP b and
a range of membrane potentials was established by including different
concentrations of malonate (0–2.3 mM) or FCCP (1 μM) in the
incubations. The ACRs of TPP+C10CO2H a or TPP
+C10NH2 b were
measured simultaneously with that of TPMP by RP-HPLC and are
plotted against the ACR of TPMP. Data are means ± SEM of three
independent incubations
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of the cations assessed here. However, the validity of this
description depends on only the monocationic forms of the
molecules being membrane permeant. Equation 1 would not
hold for a more lipophilic dicationic form that was membrane
permeant, or where the conjugate base of the weak acid was a
delocalised anion that facilitated membrane permeation. Even
so, Eq. 1 and Figs. 5 and 6 give a useful simplified description
of the mitochondrial uptake of lipophilic cations conjugated to
weak acids and bases under most biological conditions.
In summary, we have shown that lipophilic cations incor-
porating weak acids or bases can be targeted to mitochondria.
By providing a foundation for the design of a greatly expand-
ed range of compounds that can be taken up by mitochondria,
this work opens the way for the rational design of many more
mitochondria-targeted drugs and probes.
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